[
  {
    "ts": null,
    "headline": "2 Dividend Stocks to Buy for Decades of Passive Income",
    "summary": "Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings.  In 2013, AbbVie (NYSE: ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (NYSE: ABT).  AbbVie is a pharmaceutical leader with a large portfolio of approved products, none more important than a duo of immunology medicines: Skyrizi and Rinvoq.",
    "url": "https://finnhub.io/api/news?id=b70e184446f91d32dbc2dad884ce90f0633ca7e042caee3dde0283798be966e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751805900,
      "headline": "2 Dividend Stocks to Buy for Decades of Passive Income",
      "id": 135775729,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings.  In 2013, AbbVie (NYSE: ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (NYSE: ABT).  AbbVie is a pharmaceutical leader with a large portfolio of approved products, none more important than a duo of immunology medicines: Skyrizi and Rinvoq.",
      "url": "https://finnhub.io/api/news?id=b70e184446f91d32dbc2dad884ce90f0633ca7e042caee3dde0283798be966e7"
    }
  },
  {
    "ts": null,
    "headline": "IGA: Strong Performance From Foreign Exposure And Fully-Covered Distribution",
    "summary": "IGA: Strong Performance From Foreign Exposure And Fully-Covered Distribution",
    "url": "https://finnhub.io/api/news?id=dd4183d43e0eee82122b159439b318ae9759bbeb88ace8f19885a8a622793354",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751798693,
      "headline": "IGA: Strong Performance From Foreign Exposure And Fully-Covered Distribution",
      "id": 135775929,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=dd4183d43e0eee82122b159439b318ae9759bbeb88ace8f19885a8a622793354"
    }
  },
  {
    "ts": null,
    "headline": "NYLI Income Builder Fund Q1 2025 Commentary",
    "summary": "NYLI Income Builder Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=7ceeff97484e949db72144ad93338a95a456631a1f33b28a362a62fbad454cd4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751791500,
      "headline": "NYLI Income Builder Fund Q1 2025 Commentary",
      "id": 135775524,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7ceeff97484e949db72144ad93338a95a456631a1f33b28a362a62fbad454cd4"
    }
  }
]